IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Keros Therapeutics Inc

CUSIP: 492327100 | 1 institutional holders

Quarters

Q2 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2020

Fosun International Ltd83,545
0.0% of portfolio›$3.1K
StyleTurnoverLocationFiled
Fosun International Ltd
83,545$3.1K0.0%GARPLowHong Kong, France2020-08-12